MCM
EVH icon

Moore Capital Management’s Evolent Health EVH Stock Holding History

Moore Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-50,000
Closed -$1.05M – 306
2018
Q2 		$1.05M Buy
+50,000
New +$946K 0.03% 213

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Moore Capital Management's EVH Position: Q3 2018 in Review

Moore Capital Management sold out of Evolent Health (EVH) in Q3 2018, closing a stake of 50,000 shares — an estimated $1.05M sold.

Moore Capital Management first reported a position in EVH in Q2 2018 and held it in 1 quarter. The position peaked at $1.05M in Q2 2018. 187 funds tracked by Wall St. Rank hold EVH as of Q3 2018.

  • Moore Capital Management reported no remaining Evolent Health position as of Q3 2018 after selling out during the quarter.
  • Moore Capital Management sold 50,000 Evolent Health shares in Q3 2018, an estimated $1.05M.
  • Moore Capital Management first reported a position in Evolent Health in Q2 2018 and held it in 1 quarter.
  • Moore Capital Management's Evolent Health position peaked at $1.05M in Q2 2018.
  • 187 funds tracked by Wall St. Rank held Evolent Health as of Q3 2018.

Based on Moore Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.